Ng, Kenrick https://orcid.org/0000-0001-9132-4075
Tyers, Birth-Lynn
Ghose, Aruni
Kassamali, Abbas
El Debri, Reem
Shamash, Jonathan
Article History
Received: 11 September 2025
Accepted: 19 December 2025
First Online: 19 January 2026
Declarations
:
: No assistance for medical writing was received.
: Kenrick Ng has received advisory board and speaker fees from Pfizer, AstraZeneca, Bayer, and UCB Pharmaceuticals, and research funding from Prostate Cancer Research. Kenrick Ng is an Editor-in-Chief of Oncology and Therapy . Kenrick Ng was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Jonathan Shamash has received speaker fees from Bayer. The remaining authors (Birth-Lynn Tyers, Aruni Ghose, Abbas Kassamali and Reem El Debri) declare no conflicts of interest.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.